{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:20:47Z","timestamp":1761898847452,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.cancergen.2012.02.003","type":"journal-article","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T07:41:06Z","timestamp":1338968466000},"page":"255-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acute panmyelosis with myelofibrosis with EVI1 amplification"],"prefix":"10.1016","volume":"205","author":[{"given":"Beata","family":"Grygalewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Woroniecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pastwi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Rygier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Borg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Makuch-\u0141asica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Patkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Pie\u0144kowska-Grela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2012.02.003_bib1","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/sj.leu.2400880","article-title":"The EVI1 gene in myeloid leukemia","volume":"11","author":"Nucifora","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2012.02.003_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2005.09.020","article-title":"EVI1 and hematopoetic disorders: history and perspectives","volume":"368","author":"Nucifora","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.cancergen.2012.02.003_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/gcc.20295","article-title":"EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements","volume":"45","author":"Poppe","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.02.003_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0145-2126(00)00031-X","article-title":"The EVI1 gene-its role in pathogenesis of human leukemias","volume":"24","author":"Jolkowska","year":"2000","journal-title":"Leukemia Res"},{"key":"10.1016\/j.cancergen.2012.02.003_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1079-9796(03)00159-1","article-title":"The role of EVI1 in normal and leukemic cells","volume":"31","author":"Buonamici","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.cancergen.2012.02.003_bib6","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1182\/blood-2007-10-119230","article-title":"High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated","volume":"111","author":"Lughart","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2012.02.003_bib7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood.V84.4.1243.1243","article-title":"Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations","volume":"84","author":"Rusell","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2012.02.003_bib8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/gcc.20532","article-title":"Expression and prognostic significance of different mRNA 5\u2032-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1\/EVI1 overexpression both predict short remission duration","volume":"47","author":"Haas","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.02.003_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0165-4608(92)90208-P","article-title":"Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoesis bring further evidence to the existence of a 3q21q26 syndrome","volume":"59","author":"Jotterand Bellomo","year":"1992","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2012.02.003_bib10","unstructured":"Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer (http:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman). Accessed August\u00a02010."},{"key":"10.1016\/j.cancergen.2012.02.003_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cancergencyto.2005.10.007","article-title":"Translocation (3;8)(q26;q24): a recurrent chromosomal abonormality in myelodysplastic syndrome and acute myeloid leukemia","volume":"166","author":"Lin","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2012.02.003_bib12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2002-05-1459","article-title":"High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients","volume":"101","author":"Barjesteh van Waalwijk van Doorn-Khosrovani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2012.02.003_bib13","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa040465","article-title":"Prognostically useful gene-expression profiles in acute myeloid leukemia","volume":"350","author":"Valk","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cancergen.2012.02.003_bib14","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1038\/sj.onc.1209403","article-title":"Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K\/AKT","volume":"25","author":"Liu","year":"2006","journal-title":"Oncogene"},{"year":"2009","series-title":"ISCN 2009: an international system for human cytogenetic nomenclature","key":"10.1016\/j.cancergen.2012.02.003_bib15"},{"year":"2008","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","key":"10.1016\/j.cancergen.2012.02.003_bib16"},{"key":"10.1016\/j.cancergen.2012.02.003_bib17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.gene.2007.04.012","article-title":"The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions","volume":"396","author":"Wieser","year":"2007","journal-title":"Gene"},{"key":"10.1016\/j.cancergen.2012.02.003_bib18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/modpathol.3800348","article-title":"Acute panmyelosis with myelofibrosis: an entity distinct from acute megakaryoblastic leukemia","volume":"18","author":"Orazi","year":"2005","journal-title":"Modern Pathology"},{"key":"10.1016\/j.cancergen.2012.02.003_bib19","first-page":"421239","article-title":"Succesful Control of Acute Myelofibrosis with Lenalidomide","author":"Vassilopoulos","year":"2010","journal-title":"Case Report Med"},{"key":"10.1016\/j.cancergen.2012.02.003_bib20","first-page":"146","article-title":"Long-term Follow-up of autologous peripheral blood stem cell transplantation in the treatment of a patient with acute panmyelosis with myelofibrosis","volume":"91","author":"Ngirabacu","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2012.02.003_bib21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/10428190310001625692","article-title":"Acute Panmyelosis with Myelofibrosis","volume":"45","author":"Thiele","year":"2004","journal-title":"Leukemia and Lymphoma"},{"key":"10.1016\/j.cancergen.2012.02.003_bib22","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)","volume":"100","author":"Byrd","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2012.02.003_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/leu.2010.293","article-title":"Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevance","volume":"25","author":"Thiel","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2012.02.003_bib24","first-page":"336","article-title":"Cryptic 3q26 aberrations particularly explain abnormal expression of EVI1 in AML cases without cytogenetically recognizable translocations in this locus","volume":"92","author":"Sanne","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2012.02.003_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cancergencyto.2007.05.007","article-title":"Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24)","volume":"177","author":"Lennon","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2012.02.003_bib26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/gcc.20417","article-title":"Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia\u2013derived childhood acute myeloid leukemia with biallelic FANCD1\/BRCA2 disruption","volume":"46","author":"Meyer","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.02.003_bib27","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1182\/blood-2005-03-1115","article-title":"Recurrent retroviral vector integration at the Mds1\/Evi1 locus in nonhuman primate hematopoietic cells","volume":"106","author":"Calmels","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2012.02.003_bib28","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood-2005-03-1113","article-title":"Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells","volume":"106","author":"Du","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2012.02.003_bib29","first-page":"211","article-title":"Molecular analysis of EVI1, a zinc finger oncogene involved in myeloid leukemia","volume":"211","author":"Lopingco","year":"1996","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.cancergen.2012.02.003_bib30","doi-asserted-by":"crossref","first-page":"e8676","DOI":"10.1371\/journal.pone.0008676","article-title":"Identification of two critically deleted regions within chromosome segment 7q35-q36 in EVI1 deregulated myeloid leukemia cell lines","volume":"5","author":"De Weer","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cancergen.2012.02.003_bib31","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1073\/pnas.93.4.1642","article-title":"Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family","volume":"93","author":"Fears","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2012.02.003_bib32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.leu.2400584","article-title":"The leukemia-associated gene MDS1\/EVI1 is a new type of GATA-binding transactivator","volume":"11","author":"Soderholm","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2012.02.003_bib33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/sj.leu.2401360","article-title":"MDS1\/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1\/MDS1\/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1","volume":"13","author":"Sood","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2012.02.003_bib34","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/sj.leu.2401585","article-title":"Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements","volume":"13","author":"Sitailo","year":"1999","journal-title":"Leukemia"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212000476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212000476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:37:33Z","timestamp":1761896253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776212000476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S2210776212000476"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.02.003","relation":{},"ISSN":["2210-7762"],"issn-type":[{"type":"print","value":"2210-7762"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute panmyelosis with myelofibrosis with EVI1 amplification","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}